Structure Therapeutics Inc.
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small…
Biotechnology
US, South San Francisco [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Structure Therapeutics Inc. (GPCR) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology Average | - - | - - | - - | 679,399.98 | 23,527.96 | 2,654.82 | 1,008.73 | 828.78 | 0.00 | 24.5546 | 59.33 | -0.4115 | -16.0512 | -0.07 | -0.67 | 5.8765 | - - | ||
| Maximum | - - | - - | - - | 66,761,212.00 | 1,187,075.00 | 264,468.00 | 99,050.00 | 262,089.00 | 0.02 | 1,336.3467 | 3,715.80 | 3.0051 | 85.3485 | 0.40 | 2.21 | 61.5621 | - - | ||
| Minimum | - - | - - | - - | 0.00 | -5.00 | -10,603.00 | -56,335.00 | -50,658.00 | 0.00 | -233.7460 | -132.82 | -101.7758 | -1,444.7800 | -1.56 | -84.15 | 0.0000 | - - | ||
| Morphic Holding, Inc. MORF | 56.99 | 0.02 0.04% | 1,739 vs. 2,453 | 2,862.00 | 0.00 | -45.00 | -47.00 | -494.00 | -0.9100 | -9.0840 | 0.0000 | 0.0000 | 0.0000 | -0.0683 | -0.0663 | 37.1953 | 50.00 | ||
| Structure Therapeutics Inc. GPCR | 28.27 | -0.31 -1.07% | 91 vs. 825 | 1,618.00 | 0.00 | -26.00 | -34.00 | -232.00 | -0.5600 | -18.2892 | 0.0000 | 0.0000 | 0.0000 | -0.0606 | -0.0569 | 18.5046 | 57.00 | ||
| DICE Therapeutics, Inc. DICE | 47.55 | 0.03 0.06% | 4,332 vs. 1,753 | 2,270.00 | 0.00 | -34.00 | -30.00 | -248.00 | -0.7400 | -15.7831 | 0.0000 | 0.0000 | 0.0000 | -0.0671 | -0.0632 | 25.6858 | 47.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.